Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Clonidine Hydrochloride 10 mg/mL in Inorpha Solution

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Page(s):  146

Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Clonidine Hydrochloride 10 mg/mL in Inorpha Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, clonidine hydrochloride, liquid dosage form, opioid withdrawal, premeasured vehicle, alcohol withdrawal, tobacco withdrawal

Related Categories: EXCIPIENTS, FORMULATIONS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Allen Loyd V Jr
Mar/Apr 2018
Pg. 146

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 414

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes
Xu Quanyun A
, Trissel Lawrence A, Pham Lien
Jan/Feb 2002
Pg. 66-69

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 44

Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
May/Jun 2020
Pg. 252-262

Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 71

Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018
Pg. 516-526

Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 457

Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2022
Pg. 342-351

Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67

Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms
Gupta Vishnu D
Sep/Oct 2009
Pg. 445-446

Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
Jul/Aug 2023
Pg. 329

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns
Allen Loyd V Jr
Jan/Feb 1999
Pg. 25-29

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form
Gupta Vishnu D
Jul/Aug 2007
Pg. 347-348

Hydralazine Hydrochloride 10 mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2022
Pg. 323-324

Return to Top